Emerging technologies in autoantibody testing for rheumatic diseases

Emerging technologies in autoantibody testing for rheumatic diseases

Abstract Testing for the presence of antinuclear antibodies (ANAs) is a key step in the diagnosis of systemic lupus erythematosus (SLE) and other systemic autoimmune rheumatic diseases (SARD). The standard slide-based indirect immunofluorescence (IIF) test is widely used, but is limited by a relativ...

Full description

Bibliographic Details
Main Authors: Nancy J. Olsen, May Y. Choi, Marvin J. Fritzler
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Arthritis Research & Therapy
Subjects:
Systemic autoimmune rheumatic diseases
Systemic lupus erythematosus
Antinuclear antibodies
Autoantibodies
Biomarkers
Point of care testing
Online Access:http://link.springer.com/article/10.1186/s13075-017-1380-3

Internet

http://link.springer.com/article/10.1186/s13075-017-1380-3

Similar Items